MYD88 and neoplasm: While previous studies have demonstrated that the activation of the TLR2-MyD88 pathway in mammary and gastrointestinal epithelial cells leads to tumor growth and promotes carcinogenesis45, 46, TLR5 activation with flagellin inhibits cancer cell growth and mediates potent anti-tumor activity in breast cancer36.